🇺🇸 FDA
Patent

US 9839684

Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance

granted A61KA61K2039/523A61K2039/5252

Quick answer

US patent 9839684 (Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance) held by BIOVAXIM LIMITED expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOVAXIM LIMITED
Grant date
Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/523, A61K2039/5252, A61K2039/54, A61K2039/541